Search
Alaunos Therapeutics Inc
TCRTAdd to Watchlist
2.230USD
-0.010-0.45%
Close 06/17, 16:00（ET）Quotes delayed by 15 min
5.47MMarket Cap
LossP/E TTM
Alaunos Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-17The current valuation score of Alaunos Therapeutics Inc is 6.28, ranking 348 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.12, which is -134.48% below the recent high of 0.38 and -318.69% above the recent low of -4.67.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
